Middle East and Africa Irritable Bowel Syndrome Treatment market

Middle-east accounted for the larger market share in 2017 in the middle east and africa irritable bowel syndrome treatment market, and is expected to reach usd 139.30 million in 2023 from usd 101.50 million in 2017. however, africa is the fastest growing market, which is expected to grow at a cagr of 6.00% during the forecast period 2018 - 2023. ibs d segment accounted for the largest market share in 2017, this market is expected to reach usd 123.30 million in 2023 from usd 85.40 million in 2017. this market is projected to grow at a cagr of 5.85% during the forecast period from 2018 - 2023. however, ibs d segment is the fastest growing market, which is expected to grow at a cagr of 5.85% during the forecast period 2018 - 2023. linaclotide segment accounted for the largest market share in 2017, this market is expected to reach usd 66.00 million in 2023 from usd 46.60 million in 2017. this market is projected to grow at a cagr of 5.50% during the forecast period from 2018 - 2023. hospitals segment accounted for the largest market share in 2017, this market is expected to reach usd 86.40 million in 2023 from usd 60.70 million in 2017. this market is projected to grow at a cagr of 5.60% during the forecast period from 2018 - 2023.